胶束
药品
化学
药物输送
药理学
毒品携带者
内脏利什曼病
溶解度
利什曼病
生物利用度
泊洛沙姆
靶向给药
生物物理学
活性成分
利什曼原虫
体外
组合化学
堆积
毒性
剂型
锑葡胺
水溶液
IC50型
药学
疏水效应
葡甲胺
利什曼原虫
作者
Ana G. Gomes‐Alves,Aida Varela-Moreira,Tânia Cruz,Margarida Duarte,Helena Castro,Rui Moreira,Ana S Ressureição,Gert Storm,Wim E. Hennink,Ana M. Tomás
标识
DOI:10.1016/j.ijpharm.2025.126316
摘要
> 20-50 µM versus < 9 µM for the free drugs). Additionally, in a murine model of visceral leishmaniasis, the micellar formulation facilitated targeted drug accumulation in organs typically affected by the disease, reaching concentrations of approximately 2 µg in the liver, 0.4 µg in the spleen and 0.015 µg in the bone marrow after 24 h. In contrast, the free drug was either undetectable or present in markedly lower concentrations. These findings highlight the potential of mPEG-b-p(HPMAm-Bz) micelles as a promising strategy to enhance solubility of poorly water-soluble drugs and as a safe delivery system for antileishmanial therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI